12 Health Care Stocks Moving In Friday’s Pre-Market Session

 

 

Gainers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 84.7% to $0.83 during Friday’s pre-market session. The company’s market cap stands at $8.3 million.
  • Akebia Therapeutics (NASDAQ:AKBA) stock moved upwards by 35.91% to $0.48. The company’s market cap stands at $88.0 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock increased by 19.12% to $1.37. The market value of their outstanding shares is at $8.6 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 13.71% to $1.99. The market value of their outstanding shares is at $4.0 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 10.9% to $1.22. The market value of their outstanding shares is at $21.5 million.
  • Mereo BioPharma Group (NASDAQ:MREO) shares rose 10.71% to $1.24. The market value of their outstanding shares is at $145.0 million.

Losers

  • Ensysce Biosciences (NASDAQ:ENSC) shares fell 17.6% to $0.72 during Friday’s pre-market session. The company’s market cap stands at $24.7 million.
  • Encompass Health (NYSE:EHC) stock decreased by 17.04% to $46.5. The market value of their outstanding shares is at $4.6 billion.
  • Dermata Therapeutics (NASDAQ:DRMA) shares fell 13.83% to $0.56. The market value of their outstanding shares is at $5.1 million.
  • Revelation Biosciences (NASDAQ:REVB) shares declined by 11.72% to $0.98. The company’s market cap stands at $14.7 million.
  • Biophytis (NASDAQ:BPTS) shares decreased by 11.51% to $1.0. The market value of their outstanding shares is at $14.7 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) stock declined by 10.28% to $0.39. The company’s market cap stands at $35.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

3 Minutes To Boost Your Earnings: 3 High-Yielding Dividend Stocks In Energy Sector From Wall Street’s Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

NAT